Janssen Korea held a press conference to celebrate the launch of Asia's first approved multidrug-resistant tuberculosis (MDR-TB) treatment 'Sirturo'
On Apr 21, Janssen Korea held a press conference to celebrate the launch of Asia's first approved multidrug-resistant tuberculosis (MDR-TB) treatment 'Sirturo' (ingredient: Bedaquiline fumarate).
The press conference was composed of twn sessions including last March 21 tyureo ® sikyak wife stand...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
